Berlin (vfa). The service sector is important, especially for the state of Berlin. Nonetheless, Berlin needs industry, and Berlin has industry. Added value and, as a result, jobs, high taxes and profits come from industry. In this respect, the pharmaceutical industry has a special significance for Berlin. It is one of the city’s few industrial growth centers and a growth engine within the region’s important health care sector.

"Renowned companies of the pharmaceutical industry are located or have their German headquarters in Berlin, such as Pfizer, Berlin Chemie or Takeda, or they maintain important sites here, like Bayer or Sanofi. Nine percent of pharmaceutical industry staff in Germany, i.e. 9,589 employees, have found their job with pharmaceutical companies in Berlin. At EUR 5.6 billion, about 14% of the overall German sales of pharmaceutical products in 2011 were also located in Berlin, which confirms the image of a significant pharmaceutical location. With sales of almost EUR 600,000 per employee, the pharmaceutical industry in Berlin holds an absolute top position among all industries that are active in the city," Birgit Fischer said on behalf of the research-based pharmaceutical companies.

Fischer continued: "Berlin is an important and interesting location for the health care industry in Germany. A nationally and internationally vibrant medical location is evolving between renowned hospitals, research institutions and well-known companies of the pharmaceutical industry. A city like Berlin will also be able to benefit economically from this fact, and even more so in the future. For the future, we need the following in Berlin:

More health research

  • There are a variety of institutions in the city where additional health or health care research programs could be established, such as the German National Academy of Science and Engineering (ACATECH) or the Innovation Center Technologies for Health and Foods (IGE) at Technical University Berlin (TU).


Even better business location policy based on

  • Concentration of the city’s business development efforts;
  • Elimination of bureaucracy and overregulation;
  • Networked marketing for Berlin as a health care location.”


Fischer’s conclusion: "If we wish to make even better use of Berlin’s strengths, we must think in terms of networks and all players in Berlin must also become networkable. The pharmaceutical industry and the vfa, for one thing, have long turned their attention to becoming networkable."


The vfa is the trade association of the research-based pharmaceutical companies in Germany. It represents the interests of 45 globally leading pharmaceutical companies and more than 100 subsidiaries and affiliated companies in the areas of health, research and economic policy. The vfa member companies make up about two-thirds of the German pharmaceutical market and employ approx. 85,000 people in Germany, including more than 17,000 in research and development. Follow us on Twitter: www.twitter.com/vfapharma